Dual-targeting Yap1 and Cox2 solely in Panc02 cells or in fibroblasts had no discernable effect on Gem response, unlike previous reports that dual-targeting Yap1 and Cox2 only in cancer cells enhances chemotherapy efficacy in colon cancer and bladder cancer26,27. The gene discussed is GEM; the disease is cancer.